Arizona State Retirement System’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$993K Buy
13,979
+2,232
+19% +$146K 0.01% 1171
2026
Q1
$795K Sell
11,747
-137
-1% -$7.76K ﹤0.01% 1223
2025
Q4
$493K Sell
11,884
-507
-4% -$21K ﹤0.01% 1492
2025
Q3
$499K Buy
12,391
+187
+2% +$5.44K ﹤0.01% 1520
2025
Q2
$317K Buy
12,204
+260
+2% +$6.26K ﹤0.01% 1713
2025
Q1
$293K Buy
11,944
+91
+0.8% +$2.56K ﹤0.01% 1698
2024
Q4
$340K Buy
+11,853
New +$406K ﹤0.01% 1683

Other funds holding CGON

Arizona State Retirement System's CGON Position: Q2 2026 in Review

Arizona State Retirement System increased its CG Oncology (CGON) stake by 19% in Q2 2026, buying an estimated $146K and bringing the position to 13,979 shares worth $993K. The position accounts for 0.01% of the portfolio, ranked #1171.

Arizona State Retirement System first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Arizona State Retirement System held 13,979 shares of CG Oncology worth $993K as of Q2 2026.
  • Arizona State Retirement System bought 2,232 CG Oncology shares in Q2 2026, an estimated $146K.
  • CG Oncology made up 0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1171 holding.
  • Arizona State Retirement System first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.